These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6094985)

  • 1. Herpes simplex virus latency in immunosuppressed mice.
    Rotula A; Di Luca D; Gerna G; Manservigi R; Tognon M; Cassai E
    Microbiologica; 1984 Jul; 7(3):219-27. PubMed ID: 6094985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous antibody is protective against HSV-1 infection of the immunocompromised mouse.
    Alexander TS; Rosenthal KS
    J Lab Clin Med; 1990 Sep; 116(3):400-7. PubMed ID: 2169516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    Mitchell BM; Stevens JG
    J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphology of central nervous system disease in immunosuppressed mice after peripheral herpes simplex virus inoculation. Trigeminal root entry zone.
    Townsend JJ; Baringer JR
    Lab Invest; 1979 Feb; 40(2):178-82. PubMed ID: 219289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSV-1 infection and immunity in immunosuppressed mice.
    Litwińska B; Sadowski W; Kańtoch M
    Acta Virol; 1987 Aug; 31(4):298-306. PubMed ID: 2892379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of tumours in mice chronically infected with herpes simplex virus.
    Barinsky IF; Spynu KI; Talalaeva AF; Vanag KA
    Acta Virol; 1979 Sep; 23(5):367-74. PubMed ID: 42295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does restriction enzyme analysis reveal changes in herpes simplex virus DNA after latency in mouse ganglia?
    Wolff MH; Krämer S; Schneweis KE
    Microbiologica; 1986 Apr; 9(2):139-45. PubMed ID: 3012286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of ara-A on the experimental herpes simplex virus encephalitis--pathology and fluctuation of the cerebrospinal fluid and serum antibody levels].
    Kurata T; Ohtani S; Fukushima S; Hayashi K; Yamamoto A; Aoyama Y; Mizutani H
    No To Shinkei; 1983 Sep; 35(9):913-20. PubMed ID: 6317002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
    Cheng H; Tumpey TM; Staats HF; van Rooijen N; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1402-9. PubMed ID: 10798656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR; Yang L; Voytek C; Margolis TP
    Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression of mice by cyclophosphamide (CyP) and cyclosporin A (CsA) changes the course of HSV-1 infection and the distribution of viral DNA in target organs.
    Berkowitz-Balshayi C; Rösen-Wolff A; Darai G; Becker Y
    In Vivo; 1995; 9(2):155-62. PubMed ID: 7548792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasion of the central nervous system by herpes simplex virus type 1 after subcutaneous inoculation of immunosuppressed mice.
    Oakes JE
    J Infect Dis; 1975 Jan; 131(1):51-7. PubMed ID: 162925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity.
    Nash AA; Phelan J; Gell PG; Wildy P
    Immunology; 1981 Jun; 43(2):363-9. PubMed ID: 6265348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons.
    Valyi-Nagy T; Olson SJ; Valyi-Nagy K; Montine TJ; Dermody TS
    Virology; 2000 Dec; 278(2):309-21. PubMed ID: 11118355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1.
    Halford WP; Gebhardt BM; Carr DJ
    Virology; 1997 Nov; 238(1):53-63. PubMed ID: 9375008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of humoral and cell-mediated immunity aspects in mice with experimental latent herpes infection.
    Danielescu G; Botnariuc I; Cajal N
    Virologie; 1985; 36(2):85-94. PubMed ID: 2994290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.